The University of Chicago Header Logo

Connection

Walter M. Stadler to Protease Inhibitors

This is a "connection" page, showing publications Walter M. Stadler has written about Protease Inhibitors.
Connection Strength

0.225
  1. Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium study. J Clin Oncol. 2004 Jan 01; 22(1):115-9.
    View in: PubMed
    Score: 0.225
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.